Staff Spotlight: Jennifer Hannant

7th August 2018

We’re launching a new ‘Staff Spotlight’ feature: a Q&A with members of Team QuantuMDx to gain an insight into their role, career highlights and ambitions.

Read More

The Consul General of India visits QuantuMDx

15th May 2018

The Consul General of India, Dr Aman Puri, visited Newcastle upon Tyne yesterday which included a tour of laboratories at QuantuMDx Group Limited (QuantuMDx). As a life science…

Read More

QuantuMDx achieves ISO 13485: 2016 certification

29th March 2018

QuantuMDx Group has been awarded ISO 13485: 2016 certification – representing the highest standard of quality a medical devices company can achieve. ISO 13485…

Read More

World TB Day: Engaging end users when developing diagnostics

22nd March 2018

To coincide with World TB Day, Mark Ware, Patient Engagement and Training Manager at QuantuMDx, highlights the importance of end user engagement when devising point of…

Read More

QuantuMDx raises $12m and strengthens Board as company eyes commercialisation of Q-POC™ portable MDx platform

23rd January 2018

Newcastle upon Tyne, UK – 23 January 2018 Life science tools and diagnostics company QuantuMDx announced today it has closed a $12m funding round.

Read More

UK’s Gateshead Millennium Bridge Lights Up Red for World’s Deadliest Infectious Disease on World TB Day

24th March 2017

[vc_row][vc_column][vc_column_text]24th March 2017, Newcastle upon Tyne, UK. Gateshead’s Millennium Bridge will today join a wealth of international landmarks in lighting up red to mark…

Read More

Achieving gender equality with diagnostics

8th March 2017

We’re on the precipice of achieving truly monumental strides for gender equality. Progress has been made in recent years to achieve gender equality for women…

Read More

Press Release: On World Cancer Day, Global Good and QuantuMDx Partner to Combat Cervical Cancer

2nd February 2017

2 February 2017, Newcastle upon Tyne, UK QuantuMDx Group announce an assay co-development and commercialisation agreement with The Global Good Fund, managed by Intellectual Ventures,…

Read More

Press Release: QuantuMDx CEO Elaine Warburton OBE appointed to Precision Medicine Catapult Board of Directors

15th December 2016

15 December 2016, Newcastle upon Tyne QuantuMDx today announced the appointment of CEO Elaine Warburton OBE to the Precision Medicine Catapult Board of Directors as…

Read More

Press Release: QuantuMDx receives grant funding for TB diagnostic

28th November 2016

28th November 2016, Newcastle upon Tyne, UK QuantuMDx announced today that it received funding from the Bill & Melinda Gates Foundation to further develop and…

Read More